356 related articles for article (PubMed ID: 35202189)
1. Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience.
Elboga U; Sahin E; Cayirli YB; Okuyan M; Aktas G; Haydaroglu Sahin H; Dogan I; Kus T; Akkurd DM; Cimen U; Mumcu V; Kilbas B; Celen YZ
Tomography; 2022 Feb; 8(1):293-302. PubMed ID: 35202189
[TBL] [Abstract][Full Text] [Related]
2. The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG.
Shu Q; Deng M; Hu M; Liu M; Chen X; Chen Y; Cai L
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1442-1452. PubMed ID: 36609606
[TBL] [Abstract][Full Text] [Related]
3. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.
Çermik TF; Ergül N; Yılmaz B; Mercanoğlu G
Clin Nucl Med; 2022 Apr; 47(4):e333-e339. PubMed ID: 35085165
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma.
Guo C; Liu Y; Yang H; Xia Y; Li X; Chen L; Feng Y; Zhang Y; Chen Y; Huang Z
Br J Radiol; 2024 Mar; 97(1156):859-867. PubMed ID: 38290775
[TBL] [Abstract][Full Text] [Related]
5. The potential utility of [
Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/CT in Patients With SAPHO Syndrome.
Wang P; Li C; Hou G; Li Z; Jing H; Zhang W; Li F
Clin Nucl Med; 2023 Sep; 48(9):781-784. PubMed ID: 37543757
[TBL] [Abstract][Full Text] [Related]
7. First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer.
Wegen S; Roth KS; Weindler J; Claus K; Linde P; Trommer M; Akuamoa-Boateng D; van Heek L; Baues C; Schömig-Markiefka B; Schomäcker K; Fischer T; Drzezga A; Kobe C; Köhler C; Marnitz S
Clin Nucl Med; 2023 Feb; 48(2):150-155. PubMed ID: 36607364
[TBL] [Abstract][Full Text] [Related]
8. 68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients: A Head-to-Head Comparative Study.
Zheng S; Lin J; Zhu Y; Chen Y; Zhang J; Chen X; Miao W
Clin Nucl Med; 2023 Mar; 48(3):e104-e109. PubMed ID: 36723892
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.
Gündoğan C; Kömek H; Can C; Yildirim ÖA; Kaplan İ; Erdur E; Poyraz K; Güzel Y; Oruç Z; Çakabay B
Nucl Med Commun; 2022 Jan; 43(1):64-72. PubMed ID: 34661379
[TBL] [Abstract][Full Text] [Related]
10. [
Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
[TBL] [Abstract][Full Text] [Related]
11. Comparison of
Elboga U; Sahin E; Kus T; Cayirli YB; Aktas G; Okuyan M; Cinkir HY; Teker F; Sever ON; Aytekin A; Yılmaz L; Aytekin A; Cimen U; Mumcu V; Kilbas B; Eryilmaz K; Cakici D; Celen YZ
Mol Imaging Biol; 2022 Oct; 24(5):789-797. PubMed ID: 35411447
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 68Ga-FAPI-04 PET/CT with 18F-FDG PET/CT for diagnosis and staging of gastric and colorectal cancer.
Wang B; Zhao X; Liu Y; Zhang Z; Chen X; Jing F; Chen X; Hua Y; Zhao J
Nucl Med Commun; 2024 Apr; ():. PubMed ID: 38686487
[TBL] [Abstract][Full Text] [Related]
13. A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.
Zang J; Lin R; Wen X; Wang C; Zhao T; Jakobsson V; Yang Y; Wu X; Guo Z; Chen X; Zhang J; Miao W
Clin Nucl Med; 2023 Oct; 48(10):861-868. PubMed ID: 37682601
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography and computed tomography with [
Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
[TBL] [Abstract][Full Text] [Related]
15. Head-to-head comparison of [68Ga]Ga-FAPI PET and [18F]FDG PET in the detection of bone and lymph node metastasis in various cancers: A systematic review and meta-analysis.
Wu G; Wang D; Zhang W; Jia Z; Li J; Zhang L
Eur J Radiol; 2024 Feb; 171():111302. PubMed ID: 38219352
[TBL] [Abstract][Full Text] [Related]
16. [
Mu X; Huang X; Jiang Z; Li M; Jia L; Lv Z; Fu W; Mao J
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1205-1215. PubMed ID: 36495325
[TBL] [Abstract][Full Text] [Related]
17.
Kömek H; Can C; Güzel Y; Oruç Z; Gündoğan C; Yildirim ÖA; Kaplan İ; Erdur E; Yıldırım MS; Çakabay B
Ann Nucl Med; 2021 Jun; 35(6):744-752. PubMed ID: 33934311
[TBL] [Abstract][Full Text] [Related]
18. The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions.
Erol Fenercioğlu Ö; Beyhan E; Şahin R; Baloğlu MC; Arslan E; Çermik TF; Ergül N
Nucl Med Commun; 2023 Oct; 44(10):896-899. PubMed ID: 37450605
[TBL] [Abstract][Full Text] [Related]
19. The Added Value of
Gu B; Xu X; Zhang J; Ou X; Xia Z; Guan Q; Hu S; Yang Z; Song S
J Nucl Med; 2022 Jun; 63(6):875-881. PubMed ID: 34593594
[No Abstract] [Full Text] [Related]
20. Superiority of [
Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
